Analysis of survival outcomes based on molecular subtypes in breast cancer brain metastases: A single institutional cohort.

In breast cancer patients with brain metastasis, survival rates were different based on the molecular subtype of the tumor, despite various local and systemic treatments. Appropriate and tailored treatment approaches should, therefore, be considered for the different molecular subtypes.